11 June 2020
Cytokine Biomarkers Of Inflammatory Response In Covid-19 Patients
June 11, 2020 Discussions: Ultrasensitive SIMOA™ Immunoassays Impacting COVID-19, Infectious...
24 April 2019
at 11:00 AM
Why Industry Leaders Are Choosing The Simoa® Technology For Phase I – IV Clinical Studies
Listen On Demand Join Dr. Maribeth Raines, Vice President of Laboratory Services at Pacific Biomarkers...
12 December 2018
Use Of Simoa Planar Protein Multiplex Arrays As A Sensitive Biomarker Platform In Oncology Clinical Trials
Nature.com Webcasts 8AM PST | 11AM EST | 4PM GMT | 5PM CET Watch On Demand Compared to tissue-based...
21 June 2018
Ultra-sensitive Immunoassays: Beyond Biomarkers And Into PK And Immunogenicity
Speaker: Dan Sikkema, PhD, Vice President Biomarker Services, QuanterixModerator: Dr....
15 May 2018
Ultra-sensitive Detection Of Interferon Alpha Protein In Human Disease By Digital Elisa
Speaker: Dr. Darragh Duffy, Institut Pasteur, ParisModerator: Dr. Jayshan Carpen, Moderator,...
14 September 2017
Predicting Progression Of Neurodegeneration With A Blood Test: How Neurofilament Light Protein May Be A Game-changer For Therapeutic Development In Huntington’s Disease
SIMOA technology has facilitated the quantification of neurofilament light (NfL), a brain-derived protein,...
18 April 2017
Personalized Medicine: The Need For Precise Protein Quantification And Identification
Speaker: Dr. Jennifer E. Van Eyk, PhD, FAHA, FISHRProfessor of Medicine, Cedars-Sinai Medical...
02 December 2016
Novel CNS Biomarker Applications Enabled By Single-molecular Array (Simoa) Technology: Tau In Pre-clinical And Clinical Studies
This webinar led by Dr. Michelle Mielke and Dr. Stephan Kaeser will highlight the use of a Simoa custom...
05 October 2016
Blood Biomarkers For CNS Disorders
Hosted By Cambridge Healthtech Institute Click To Watch As Dr. Henrik Zetterberg And Dr. Jens Kuhle...